MCL-schema http://www.hovon.nl/studies/studies-per-ziektebeeld/nhl.html?action=showstudie&studie_id=92&categorie_id=1 vantVeer_2008_BJH_HOVON45.pdf Herrmann_2009_JCO_Dreyling.pdf MCL_Lymfoom_StadienindelingRemissiebeoordeling.htm MCL_Stadiering.htm MCL_Lymfoom_FollowUp_nietcuratief.htm MCL_R-Benda90.htm MCL_Stadiering.htm Kluin-Nelemans_2012_NEJM_Dreyling.pdf Forstpointner_2004_BLOOD_Hiddemann.pdf Dreyling_2009_HEMATOLOGY_Hiddemann.pdf Geisler_2008_BLOOD_NLG.pdf MCL_Lymfoom_StadienindelingRemissiebeoordeling.htm LUMC_2010_01.pdf LUMC_2007_01.pdf MCL_Lymfoom_StadienindelingRemissiebeoordeling.htm MCL_Stadiering.htm MCL_Diagnose.htm MCL_Rituximab.htm MCL_Stadiering.htm MCL_PECC.htm MCL_TherapiePrognose.htm MCL_Stadiering.htm MCL_Stadiering.htm MCL_Stadiering.htm MCL_R-CHOP.htm Hoster_2008_BLOOD_MIPI.pdf MCL_Stadiering.htm MCL_Lymfoom_FollowUp_nietcuratief.htm MCL_Stadiering.htm MCL_Stadiering.htm MCL_R-CHOP.htm MCL_Stadiering.htm MCL_Lymfoom_FollowUp_nietcuratief.htm MCL_R-FC.htm